JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $28,497 | -91.6% | 15,404 | -89.4% | 0.00% | -100.0% |
Q3 2022 | $339,000 | -11.3% | 144,885 | +14.9% | 0.00% | 0.0% |
Q2 2022 | $382,000 | -67.1% | 126,073 | -26.3% | 0.00% | -66.7% |
Q1 2022 | $1,162,000 | -20.4% | 171,124 | -2.1% | 0.01% | -14.3% |
Q4 2021 | $1,459,000 | +62.5% | 174,738 | +44.5% | 0.01% | +40.0% |
Q3 2021 | $898,000 | +81.8% | 120,898 | +66.5% | 0.01% | +66.7% |
Q2 2021 | $494,000 | -43.5% | 72,596 | -14.8% | 0.00% | -40.0% |
Q1 2021 | $875,000 | +31.6% | 85,195 | -10.3% | 0.01% | +25.0% |
Q4 2020 | $665,000 | -18.8% | 94,929 | -5.4% | 0.00% | -20.0% |
Q3 2020 | $819,000 | -33.9% | 100,386 | -44.1% | 0.01% | -44.4% |
Q2 2020 | $1,239,000 | +41.8% | 179,564 | -2.5% | 0.01% | +12.5% |
Q1 2020 | $874,000 | -46.3% | 184,088 | -1.3% | 0.01% | -27.3% |
Q4 2019 | $1,628,000 | +159.6% | 186,488 | -0.9% | 0.01% | +175.0% |
Q3 2019 | $627,000 | -28.1% | 188,188 | +6.8% | 0.00% | -33.3% |
Q2 2019 | $872,000 | -23.6% | 176,138 | -4.4% | 0.01% | -25.0% |
Q1 2019 | $1,142,000 | +101.4% | 184,238 | +9.5% | 0.01% | +100.0% |
Q4 2018 | $567,000 | -32.7% | 168,310 | +29.9% | 0.00% | -20.0% |
Q3 2018 | $842,000 | +45.4% | 129,530 | +71.4% | 0.01% | +66.7% |
Q2 2018 | $579,000 | – | 75,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
Granahan Investment Management | 125,533 | $778,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |